SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)

NCT03050229 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Nocturnal Hypertension
T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

Jichi Medical University

Collaborators

[object Object]
[object Object]